Silver’s performance in 2025 is drawing attention to silver-mining companies as investors look to gain exposure to…
Category:
Investing
-
-
Investing
Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027
MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through…
-
Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for traders, including mining and defense stocks, reports…
-
United States Antimony (NYSE:UAMY) said on Sunday (October 19) that it is proposing to acquire Australian company…
-
Investing
Cartier Cuts 11.0 g/t Au over 9.0 m including 30.2 g/t Au over 2.5 at Contact ; Continues to Expand High-Grade Gold North Contact Zone near Surface
Cartier Resources Inc. (″ Cartier ″ or the ″ Company ″) (TSXV: ECR,OTC:ECRFF; FSE: 6CA) is pleased…
-
Investing
Prismo Metals Announces Private Placement and Ripsey Gold Project Overlimit Silver Assay Results
(TheNewswire) NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES…
-
Investing
Standard Uranium Confirms High-Grade Uranium Mineralization up to 8.10% U3O8 at Surface on the Corvo Project
Manhattan Showing with assay results returning uranium grades ranging from 0.72% to 8.10% U3O8 in outcrop grab…
-
Trading resumes in: Company: Cardiol Therapeutics Inc. TSX Symbol: CRDL All Issues: Yes Resumption (ET): 8:00 AM…
-
Bold Ventures Inc. (TSXV: BOL,OTC:BVLDF) (the ‘Company’ or ‘Bold’) is pleased to highlight news from the area…
-
Eric Sprott announces that, on October 17, 2025, 2176423 Ontario Ltd., a corporation beneficially owned by him,…